These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2292704)

  • 1. Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine.
    Bottiglieri T; Godfrey P; Flynn T; Carney MW; Toone BK; Reynolds EH
    J Neurol Neurosurg Psychiatry; 1990 Dec; 53(12):1096-8. PubMed ID: 2292704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-adenosylmethionine levels in psychiatric and neurological disorders: a review.
    Bottiglieri T; Hyland K
    Acta Neurol Scand Suppl; 1994; 154():19-26. PubMed ID: 7524260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial.
    Kagan BL; Sultzer DL; Rosenlicht N; Gerner RH
    Am J Psychiatry; 1990 May; 147(5):591-5. PubMed ID: 2183633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-adenosylmethionine treatment of depression: a controlled clinical trial.
    Bell KM; Plon L; Bunney WE; Potkin SG
    Am J Psychiatry; 1988 Sep; 145(9):1110-4. PubMed ID: 3046382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF S-adenosylmethionine in neuropsychiatric disorders.
    Bottiglieri T; Reynolds EH; Toone BK; Carney MW
    Lancet; 1991 Jul; 338(8759):121. PubMed ID: 1676448
    [No Abstract]   [Full Text] [Related]  

  • 6. S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease.
    Linnebank M; Popp J; Smulders Y; Smith D; Semmler A; Farkas M; Kulic L; Cvetanovska G; Blom H; Stoffel-Wagner B; Kölsch H; Weller M; Jessen F
    Neurodegener Dis; 2010; 7(6):373-8. PubMed ID: 20523031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Switch mechanism in affective illness and oral S-adenosylmethionine (SAM).
    Carney MW; Chary TK; Bottiglieri T; Reynolds EH; Toone BK
    Br J Psychiatry; 1987 May; 150():724-5. PubMed ID: 3651725
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of S-adenosylmethionine (SAM) on prolactin in depressed patients.
    Thomas CS; Bottiglieri T; Edeh J; Carney MW; Reynolds EH; Toone BK
    Int Clin Psychopharmacol; 1987 Apr; 2(2):97-102. PubMed ID: 3298421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affective illness and S-adenosyl methionine: a preliminary report.
    Carney MW; Edeh J; Bottiglieri T; Reynolds EM; Toone BK
    Clin Neuropharmacol; 1986; 9(4):379-85. PubMed ID: 2425961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transmethylation cycle in the brain of Alzheimer patients.
    Mulder C; Schoonenboom NS; Jansen EE; Verhoeven NM; van Kamp GJ; Jakobs C; Scheltens P
    Neurosci Lett; 2005 Sep; 386(2):69-71. PubMed ID: 16040194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double blind, placebo controlled trial of intravenous loading with S-adenosylmethionine (SAM) followed by oral SAM therapy in patients with knee osteoarthritis.
    Bradley JD; Flusser D; Katz BP; Schumacher HR; Brandt KD; Chambers MA; Zonay LJ
    J Rheumatol; 1994 May; 21(5):905-11. PubMed ID: 8064733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-adenosylmethionine influences monoamine metabolism.
    Bottiglieri T; Laundy M; Martin R; Carney MW; Nissenbaum H; Toone BK; Johnson AL; Reynolds EH
    Lancet; 1984 Jul; 2(8396):224. PubMed ID: 6146777
    [No Abstract]   [Full Text] [Related]  

  • 13. The switch mechanism and the bipolar/unipolar dichotomy.
    Carney MW; Chary TK; Bottiglieri T; Reynolds EH
    Br J Psychiatry; 1989 Jan; 154():48-51. PubMed ID: 2673478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer's disease.
    Arlt S; Schwedhelm E; Kölsch H; Jahn H; Linnebank M; Smulders Y; Jessen F; Böger RH; Popp J
    J Alzheimers Dis; 2012; 31(4):751-8. PubMed ID: 22710910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyunsaturated fatty acid and S-adenosylmethionine supplementation in predementia syndromes and Alzheimer's disease: a review.
    Panza F; Frisardi V; Capurso C; D'Introno A; Colacicco AM; Di Palo A; Imbimbo BP; Vendemiale G; Capurso A; Solfrizzi V
    ScientificWorldJournal; 2009 May; 9():373-89. PubMed ID: 19468660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: a possible indicator for immunoactivation.
    Hampel H; Müller-Spahn F; Berger C; Haberl A; Ackenheil M; Hock C
    Dementia; 1995; 6(6):348-54. PubMed ID: 8563789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S-adenosylmethionine and affective disorder.
    Carney MW; Toone BK; Reynolds EH
    Am J Med; 1987 Nov; 83(5A):104-6. PubMed ID: 3318437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between the antidepressant activity and of S-adenosylmethionine (SAMe) and that of some tricyclic drugs.
    Miccoli L; Porro V; Bertolino A
    Acta Neurol (Napoli); 1978; 33(3):243-55. PubMed ID: 371351
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence of brain methyltransferase inhibition and early brain involvement in HIV-positive patients.
    Keating JN; Trimble KC; Mulcahy F; Scott JM; Weir DG
    Lancet; 1991 Apr; 337(8747):935-9. PubMed ID: 1678030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid S-adenosylmethionine (SAMe) and glutathione concentrations in HIV infection: effect of parenteral treatment with SAMe.
    Castagna A; Le Grazie C; Accordini A; Giulidori P; Cavalli G; Bottiglieri T; Lazzarin A
    Neurology; 1995 Sep; 45(9):1678-83. PubMed ID: 7675226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.